Local Acetaldehyde-An Essential Role in Alcohol-Related Upper Gastrointestinal Tract Carcinogenesis

Area of Science:

• Microbiology
• Gastroenterology
• Oncology

Background:

• The upper gastrointestinal (GI) tract mucosa is exposed to acetaldehyde (ACH), a carcinogenic ethanol metabolite, influenced by the resident microbiome.
• Poor oral health, characterized by dysbiosis, elevates opportunistic pathogen growth and can double local ACH production, a key factor in oral and esophageal carcinogenesis.
• Genetic variations, like aldehyde dehydrogenase 2 gene mutations, significantly increase ACH exposure and upper GI cancer risk in alcohol consumers.

Purpose of the Study:

• To establish a human cancer model demonstrating the causal link between acetaldehyde and upper GI tract carcinogenesis.
• To explore novel methods for quantitatively assessing acetaldehyde carcinogenicity in the human oropharynx.
• To investigate the impact of lifestyle factors and endogenous ACH production on cancer risk.

Main Methods:

• Utilizing a human cancer model based on genetic polymorphisms affecting ethanol and acetaldehyde metabolism.
• Analyzing the role of dysbiosis in oral health and its contribution to increased local ACH production.
• Evaluating the influence of acetaldehyde from various dietary sources and its presence in beverages and foodstuffs.

Main Results:

• The human cancer model conclusively proves the causal relationship between acetaldehyde exposure and upper GI tract carcinogenesis.
• Dysbiosis associated with poor oral health can lead to a 100% increase in local ACH production.
• Genetic variations significantly elevate ACH exposure, correlating with a manifold increase in upper GI cancer risk.

Conclusions:

• Acetaldehyde is a direct carcinogen in the upper GI tract, with exposure levels influenced by microbiome, genetics, and lifestyle.
• Quantitative assessment of ACH carcinogenicity in the oropharynx is now possible, offering new avenues for risk evaluation.
• Reducing local ACH exposure through smoking cessation, moderated alcohol intake, and improved oral health can significantly decrease upper GI cancer risk.